APRESS: Apical regulatory super system, serotonin, and dopamine interaction

Neuropsychiatric Disease and Treatment

Volumn 7, Issue 1, 2011, Pages 457-463

  Hinz, Marty ^a   Stein, Alvin ^b   Uncini, Thomas ^c  

^a NeuroResearch Clinics   (United States)

^b Stein Orthopedic Associates   (United States)

^c DBS Labs   (United States)

Author keywords

Catecholamine; Competitive inhibition state; Monoamine

Indexed keywords

5 HYDROXYTRYPTOPHAN; AMINE OXIDASE (FLAVIN CONTAINING); AROMATIC LEVO AMINO ACID DECARBOXYLASE; DOPAMINE; DOPAMINE TRANSPORTER; LEVODOPA; SEROTONIN; SEROTONIN TRANSPORTER; TRYPTOPHAN; TYROSINE;

AMINO ACID ANALYSIS; APICAL REGULATORY SUPER SYSTEM; ARTICLE; CATALYSIS; CATECHOLAMINE URINE LEVEL; COMPETITIVE INHIBITION; DOPAMINE METABOLISM; DOPAMINE UPTAKE; DRUG MECHANISM; HUMAN; MOLECULAR INTERACTION; MOLECULAR MODEL; MOLECULAR RECOGNITION; PARKINSON DISEASE; PROTEIN INTAKE; REGULATORY MECHANISM; SEROTONIN METABOLISM; SEROTONIN UPTAKE; SIDE EFFECT; TACHYPHYLAXIS;

EID: 80955139861     PISSN: 11766328     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/ndt.s23676     Document Type: Article

References (16)

1. Pazos-Moura C, Ortiga-Carvalho T, Gaspar de Moura E. The autocrine/ paracrine regulation of thyrotropin secretion. Thyroid. 2004;13:2.
2. O'Hara J, Ho W, Linden D, et al. Enteroendocrine cells and 5-HT availability are altered in mucosa of guinea pigs with TNBS ileitis. Am J Physiol Gastrointest Liver Physiol. 2004;287:G998-G1007.
3. Hinz M, Stein A, Uncini T. The dual-gate lumen model of renal monoamine transport. Neuropsychiatr Dis Treat. 2010;6:387-392.
4. Stein A, Hinz M, Uncini T. Amino acid-responsive Crohn's disease: a case study. Clin Exp Gastroenterol. 2010;3:171-177.
5. Hinz M, Stein A, Neff R, et al. Treatment of attention deficit hyperactivity disorder with monoamine amino acid precursors and organic cation transporter assay interpretation. Neuropsychiatr Dis Treat. 2011;7:31-38.
6. Hinz M, Stein A, Uncini T. Urinary neurotransmitter testing: considerations of spot baseline norepinephrine and epinephrine. Open Access J Urol. 2011;3:19-24.
7. Hinz M, Stein A, Uncini T. Amino acid management of Parkinson's disease: a case study. Int J Gen Med. 2011;4;165-174.
8. Hinz M. Depression. In: Kohlstadt I, editor. Food and Nutrients in Disease Management. Boca Raton, FL: CRC Press; 465-481.
9. Soares-da-Silva P, Pinto-do-O PC. Antagonistic actions of renal dopamine and 5-hydroxytryptamine: effects of amine precursors on the cell inward transfer and decarboxylation. Br J Pharmacol. 1996; 117:1187-1192.
10. Hinz M, Stein A, Trachte G, Uncini T. Neurotransmitter testing of the urine: a comprehensive analysis. Open Access J Urol. 2010;2: 177-183.
11. Hinz M, Stein A, Uncini T. A pilot study differentiating recurrent major depression from bipolar disorder cycling on the depressive pole. Neuropsychiatr Dis Treat. 2010;6:741-747.
12. Hinz M, Stein A, Uncini T. "Non-validity and clinical relevance of neurotransmitter testing": a review of the paper. Funct Neurol Rehabil Ergon. 2011. In press.
13. Trachte G, Uncini T, Hinz M. Both stimulatory and inhibitory effects of dietary 5-hydroxytryptophan and tyrosine are found on urinary excretion of serotonin and dopamine in a large human population. Neuropsychiatr Dis Treat. 2009;5:227-235.
14. Hinz M, Stein A, Uncini T. The validity of urinary monoamine assay sales under the "spot baseline urinary neurotransmitter testing marketing model." Int J Nephrol Renovascular Dis. 2011;4:101-113.
15. NeuroResearch Clinics, Inc. Medical research, medical education databases and records. 1008 Dolphin Dr, Cape Coral, FL 33904, USA.
16. Koepsell H. Organic cation transporters in the intestine, kidney, liver, and brain. Annu Rev Physiol. 1998;60:243-266.